Bioinformatics is a key discipline operating on the forefront of the biotech revolution. Despite dynamic potential, Bioinformatics remains a challenging industry, in part due to its still evolving status. A significant challenge in bioinformatics remains incorporation of different sources into one viable platform for accessing complete data. Also a major concern for this industry is the sheer lack of competent and qualified workforce, particularly for documentation. New tools are not only pushing the development of drug discovery, but also fundamentally changing the nature of biological research. The success of HGP (Human Genome Project) and breakthrough technologies in drug discovery initiatives spells significant investment opportunities for the industry.
These and other market data and trends are presented in 'Bioinformatics: A World Market Analysis' by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.
